Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ivabradine in Stage D Heart Failure on Chronic Inotropes
NCT03631654Phase 4Withdrawn
- Sponsor
- University of Maryland, Baltimore
- Start
- Oct 2020
- Primary completion
- Aug 2021
- Modality
- Small Molecules
01
Overview
Phase 4, randomised, double-blind trial in heart failure (HF) comparing Ivabradine with Placebo (2 arms). Primary endpoint: Changes in NT-proBNP and high-sensitivity troponin at 1 month. Planned start Oct 2020; status: withdrawn.
02
Drugs
ivabradine
03
Conditions
heart failure (HF)
Beyond the preview
Go deeper on NCT03631654.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03631654.